SE7702613L - Estramustinfosfatalkonolkomplex, deras framstellning och deras anvendning som mellanprodukten vid rening av foreningen och salter derav - Google Patents

Estramustinfosfatalkonolkomplex, deras framstellning och deras anvendning som mellanprodukten vid rening av foreningen och salter derav

Info

Publication number
SE7702613L
SE7702613L SE7702613A SE7702613A SE7702613L SE 7702613 L SE7702613 L SE 7702613L SE 7702613 A SE7702613 A SE 7702613A SE 7702613 A SE7702613 A SE 7702613A SE 7702613 L SE7702613 L SE 7702613L
Authority
SE
Sweden
Prior art keywords
purification
salts
preparation
estramustinfosfatalkonolkomplex
association
Prior art date
Application number
SE7702613A
Other languages
Unknown language ( )
English (en)
Other versions
SE428928B (sv
Inventor
S K Kristensson
A R Stamvik
Original Assignee
Leo Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Ab filed Critical Leo Ab
Publication of SE7702613L publication Critical patent/SE7702613L/sv
Publication of SE428928B publication Critical patent/SE428928B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J51/00Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7702613A 1976-03-10 1977-03-08 Forfarande for rening av estradiol-3-n-bis(beta-kloretyl)-karbamat-17beta-divetefosfat eller ett alkalimetallsalt eller aminsalt derav SE428928B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9451/76A GB1523035A (en) 1976-03-10 1976-03-10 Derivatives of estradiol - 17 - dihydrogen phosphates

Publications (2)

Publication Number Publication Date
SE7702613L true SE7702613L (sv) 1977-09-11
SE428928B SE428928B (sv) 1983-08-01

Family

ID=9872205

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7702613A SE428928B (sv) 1976-03-10 1977-03-08 Forfarande for rening av estradiol-3-n-bis(beta-kloretyl)-karbamat-17beta-divetefosfat eller ett alkalimetallsalt eller aminsalt derav

Country Status (17)

Country Link
US (1) US4115414A (sv)
JP (2) JPS52108963A (sv)
AT (1) AT355737B (sv)
BE (1) BE852271A (sv)
CA (1) CA1083140A (sv)
CH (1) CH633813A5 (sv)
DE (1) DE2710293C2 (sv)
DK (1) DK156007C (sv)
FR (1) FR2343752A1 (sv)
GB (1) GB1523035A (sv)
IE (1) IE45024B1 (sv)
IL (1) IL51592A (sv)
IT (1) IT1075668B (sv)
LU (1) LU76927A1 (sv)
MX (1) MX5242E (sv)
NL (1) NL7702608A (sv)
SE (1) SE428928B (sv)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2554005B2 (ja) * 1993-02-18 1996-11-13 株式会社パーマケム・アジア エストラムスチンフォスフェート又はその塩類の精製方法
US6040255A (en) * 1996-06-25 2000-03-21 Kimberly-Clark Worldwide, Inc. Photostabilization package usable in nonwoven fabrics and nonwoven fabrics containing same
US20040072889A1 (en) * 1997-04-21 2004-04-15 Pharmacia Corporation Method of using a COX-2 inhibitor and an alkylating-type antineoplastic agent as a combination therapy in the treatment of neoplasia
GB9921958D0 (en) * 1999-09-16 1999-11-17 Pharmacia & Upjohn Spa Formulations for parenteral use of estramustine phosphate and sulfoalkylether-cyclodextrins

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3299104A (en) 1963-04-09 1967-01-17 Leo Ab Certain steroid nu-bis-(haloethyl)-carbamates
GB1458372A (en) * 1973-03-05 1976-12-15 Leo Ab Steroid carbamates and allophanates

Also Published As

Publication number Publication date
JPS5526160B2 (sv) 1980-07-11
DK103577A (da) 1977-09-11
LU76927A1 (sv) 1978-10-18
GB1523035A (en) 1978-08-31
IL51592A0 (en) 1977-05-31
DE2710293A1 (de) 1977-09-15
JPS5589300A (en) 1980-07-05
BE852271A (fr) 1977-09-09
AT355737B (de) 1980-03-25
US4115414A (en) 1978-09-19
MX5242E (es) 1983-05-16
DK156007C (da) 1989-11-06
DK156007B (da) 1989-06-12
ATA157777A (de) 1979-08-15
IT1075668B (it) 1985-04-22
CA1083140A (en) 1980-08-05
FR2343752B1 (sv) 1978-10-20
IE45024B1 (en) 1982-06-02
SE428928B (sv) 1983-08-01
IE45024L (en) 1977-09-10
FR2343752A1 (fr) 1977-10-07
JPS5755720B2 (sv) 1982-11-25
NL7702608A (nl) 1977-09-13
CH633813A5 (de) 1982-12-31
DE2710293C2 (de) 1986-06-12
IL51592A (en) 1980-09-16
JPS52108963A (en) 1977-09-12

Similar Documents

Publication Publication Date Title
NL980012I2 (nl) Mometasonfuroaat-monohydraat, werkwijze om zulks te bereiden en farmaceutische samenstellingen.
NO950243D0 (no) Nye nimesulidsalt-cyklodekstrin-inklusjonskomplekser
GB1430838A (en) 7beta-amino-cepham-3-one-4-carboxylic acid compounds and process for their manufacture
DE69225410D1 (de) Herstellung von n-acetylneuraminsäure-derivaten
YU63696A (sh) Novi fenilamidin-derivati, postupci za njihovo pripremanje i njihova primena kao lekova
IT8122657A0 (it) Processo per la produzione di acetaldeide da etanolo.
SE7702613L (sv) Estramustinfosfatalkonolkomplex, deras framstellning och deras anvendning som mellanprodukten vid rening av foreningen och salter derav
DE68914236D1 (de) Verfahren zur Herstellung von Natriumhyaluronat durch Gärung.
AT336784B (de) Verfahren zur herstellung eines atoxischen, immunogenen produktes aus tetanus-toxin
PT768084E (pt) Inibidor da metastese cancerosa
NO308743B1 (no) FremgangsmÕte for fremstilling av N-acetyl- neuraminsyrederivater
EP0146239A3 (en) Bioconversion production of ascorbic acid
ATE214051T1 (de) Substituierte tetrahydropyridinderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
FI923841A0 (fi) Substituerade mandelsyraderivat, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
DE59308952D1 (de) Verfahren zur Herstellung von Distannanen
DE3869885D1 (de) Verfahren zur herstellung des gereinigten naphthalin-2,6-dicarbonsaeure-bis (2-hydroxyethyl)-esters.
ATE237621T1 (de) Herstellung von einem kristallinen amoxicillinsalz
DK0966455T3 (da) Oxirancarboxylsyrer til behandling af diabetes
ES8506351A1 (es) Un procedimiento para producir un compuesto de antraciclina
ATE103606T1 (de) Verfahren zur herstellung von sulfinylpristinamycin iib.
EP0056867A3 (de) Verfahren zur Herstellung von 4,4',7,7'-Tetrachlorthioindigo
MX167395B (es) Procedimiento para producir una formulacion topica
TW352343B (en) Water-soluble cobalt catalysts, a process for preparation and use as hydroformylation catalysts in two-phases system comprising polyethylen
ATE27281T1 (de) Verfahren zur herstellung von oxanosin.
ATE120729T1 (de) Zwischenprodukte für die herstellung von 4,5- difluoroanthranilsäure.

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7702613-6

Effective date: 19910117

Format of ref document f/p: F